Fox Chase Cancer Center News

PHILADELPHIA (April 25, 2023)—Christian Hurtz, PhD, an assistant professor at the Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine at Temple University, has been awarded a four-year $800,000 A-Award by Alex’s Lemonade Stand Foundation for Childhood Cancer. The award supports early career scientists pursuing better treatments for childhood cancer; only three such awards were granted by the organization in 2023.

PHILADELPHIA (April 24, 2023)—Eighty-six Fox Chase Cancer Center physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2023. Physicians on the list were nominated by a national survey of their professional peers.

PHILADELPHIA (April 20, 2023)—Fox Chase Cancer Center is pleased to announce the hiring of Maryam Ijaz Khan, MD, as an associate professor in the Division of Endocrinology.

PHILADELPHIA (April 18, 2023)—Fox Chase Cancer Center’s Camille Ragin, PhD, MPH, Associate Director of Diversity, Equity, and Inclusion, was appointed chair of the Minorities in Cancer Research (MICR) Council for the American Association for Cancer Research (AACR) at the AACR Annual Meeting 2023, which is being held April 14-19 at the Orange County Convention Center in Orlando, Florida.

PHILADELPHIA (April 17, 2023)—Edna “Eti” Cukierman, PhD, Co-Director of the Marvin and Concetta Greenberg Pancreatic Cancer Institute at Fox Chase Cancer Center, has been appointed chair-elect of the American Association for Cancer Research’s (AACR) Tumor Microenvironment (TME) Working Group at the AACR Annual Meeting 2023, which is being held April 14-19 at the Orange County Convention Center in Orlando, Florida.

PHILADELPHIA (April 17, 2023)—Medulloblastoma is the most common malignant brain tumor in children, and few good treatment options exist. Now researchers at Fox Chase Cancer Center have found a promising new approach using a drug that’s already being used to treat hypothyroidism.

PHILADELPHIA (April 14, 2023)—According to the 2022 Cancer Surgery Volume Report from the Pennsylvania Health Care Cost Containment Council (PHC4), Fox Chase Cancer Center performed the second highest number of cancer surgeries in the state of Pennsylvania in the last fiscal year.

PHILADELPHIA (April 14, 2023)—The African-Caribbean Cancer Consortium (AC3), a multi-institutional collaborative network that focuses on studies of cancer risk and outcomes among populations of African ancestry, will be recognized with the American Association for Cancer Research (AACR) Team Science Award at the AACR Annual Meeting 2023, to be held April 14-19 at the Orange County Convention Center in Orlando, Florida. Camille Ragin, PhD, MPH, Associate Director of Diversity, Equity, and Inclusion at Fox Chase Cancer Center, heads the network.